iTIND: How I Do It
Amin S. Herati, MD, provides an in-depth analysis of the implantation of the Temporary Implantable Nitinol Device (iTIND) for the treatment of benign prostatic hyperplasia (BPH). His discussion emphasizes the procedural details, benefits, and practical considerations of using iTIND, a minimally invasive therapy designed to relieve urinary symptoms associated with BPH.
Dr. Herati describes the indications for iTIND, highlighting its suitability for patients with moderate to severe BPH who are seeking alternatives to medication or more invasive surgical procedures. The procedural technique is meticulously detailed; Dr. Herati emphasizes the technical aspects critical to the procedure’s success, such as the precise placement of the device and careful monitoring during the implantation and removal processes.
The benefits of iTIND are highlighted, including its minimally invasive nature, rapid symptom relief, and preservation of sexual function. Additionally, the low incidence of complications, such as temporary dysuria and hematuria, is discussed. Challenges and limitations of iTIND are also addressed.
Read More